Last reviewed · How we verify
NCT04407364
MPM Medical CoMatryx Surgical Bovine Collagen Study
trial testing CoMatryx Surgical Bovine Collagen in Surgical Wound, Healed in 72 participants. Participants enrolled and being followed up; not accepting new ones.
2 April 2024
Quick facts
| Lead sponsor | MPM Medical |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 72 |
| Start date | 2 September 2020 |
| Primary completion | 2 April 2024 |
| Estimated completion | 2 May 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CoMatryx Surgical Bovine Collagen
Conditions studied
- Surgical Wound, Healed — all drugs for Surgical Wound, Healed →
Sponsor
MPM Medical
Who can join
Adults 18 to 85, any sex, with Surgical Wound, Healed. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this prospective enrollment study is to collect data confirming safety, performance and clinical benefits of the CoMatryx Surgical Collagen powder at a minimum 1-year follow-up and compare it to a historical control group who did not receive the product at the time of surgery. The primary objective is to confirm safety and clinical benefits of the product. This will be assessed by recording the rate of wound healing and incidence and frequency of wound care related complications. Relationship of complications to the product should be specified.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04407364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04407364 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MPM Medical
- Last refreshed: 5 July 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04407364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing